No Medication is Recommended for Memory Enhancement in Healthy Adults
There is no FDA-approved medication or supplement that should be routinely recommended to improve memory in otherwise healthy adults. The available evidence does not support the use of prescription cognitive enhancers, and their use carries risks that outweigh unproven benefits in this population.
Why Prescription "Smart Drugs" Should Not Be Used
The guideline evidence 1 specifically addresses cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine—these are only indicated for dementia treatment, not cognitive enhancement in healthy individuals. Even in dementia patients, the effect sizes are modest and "clinically important differences were not consistently evaluated or demonstrated" 1.
Key Problems with Off-Label Use:
- Donepezil showed only sleep architecture changes in one small study of healthy adults 2, not meaningful cognitive improvement
- Roflumilast (a PDE4 inhibitor) showed 2-3 word improvement in immediate recall 3, but this is an experimental finding with no long-term safety data in healthy populations
- Stimulants (methylphenidate, amphetamines) are being misused as "smart drugs" 4, but carry significant cardiovascular and psychiatric risks without established efficacy for cognitive enhancement
The clinical concern: Non-prescribed stimulant intake by healthy individuals poses "a range of clinical concerns" 4 including cardiovascular events, psychiatric complications, and dependency risk—all for unproven cognitive benefits.
What About Supplements?
The most recent evidence 5 from 2026 shows domain-specific, not universal cognitive benefits from nutritional supplements:
Supplements with Limited Evidence:
- DHA+EPA combinations may improve memory in specific formulations 5
- Vitamin D3 (4000 IU/day) improved visual memory only in those with baseline insufficiency (<75 nmol/L) 6
- Ginkgo biloba EGb 761 showed inconsistent results across different cognitive tests 2
Critical limitation: These effects are "significantly influenced by baseline cognitive status, age, and intervention duration" 5, meaning they cannot be universally recommended for healthy adults seeking memory enhancement.
The Bottom Line Algorithm
For a healthy adult requesting memory enhancement:
Screen for vitamin D deficiency - If 25(OH)D <75 nmol/L, consider supplementation (4000 IU/day) as this showed the most consistent benefit for visual memory 6
Do NOT prescribe:
- Cholinesterase inhibitors (no indication, adverse GI effects 1)
- Memantine (no evidence in healthy adults)
- Stimulants (risk exceeds benefit)
Counsel against self-medication with "smart drugs" due to cardiovascular and psychiatric risks 4
If considering supplements, explain that evidence is weak and effects are modest at best—DHA/EPA combinations may have marginal memory benefits 5, but "personalized interventions" based on baseline status are needed rather than blanket recommendations
Common Pitfalls to Avoid
- Do not extrapolate dementia drug data to healthy adults—the pathophysiology is entirely different
- Beware of small effect sizes—even when statistically significant, improvements of 2-3 words on recall tests 3 may not translate to real-world functional benefit
- Recognize polypharmacy risks—healthy adults taking cognitive enhancers may experience adverse effects (GI symptoms, dizziness, headache 1) without meaningful benefit
The evidence-based recommendation prioritizing morbidity and mortality: Avoid prescribing medications for memory enhancement in healthy adults, as no drug has demonstrated clinically meaningful benefit while all carry potential harms.